Stay updated on HBI-8000 + Nivolumab vs. Nivolumab in Melanoma Clinical Trial
Sign up to get notified when there's something new on the HBI-8000 + Nivolumab vs. Nivolumab in Melanoma Clinical Trial page.

Latest updates to the HBI-8000 + Nivolumab vs. Nivolumab in Melanoma Clinical Trial page
- Check2 days agoChange DetectedThe revision string at the bottom of the page was updated from v3.5.2 to v3.5.3, indicating a new build of ClinicalTrials.gov.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe history now includes a new revision entry v3.5.2 and removes the previous v3.5.0.SummaryDifference0.1%

- Check24 days agoNo Change Detected
- Check45 days agoChange DetectedA new Revision: v3.5.0 entry was added and the prior Revision: v3.4.3 entry was removed in the Record History.SummaryDifference0.1%

- Check52 days agoChange DetectedRevision: v3.4.3 is now shown, replacing the previous v3.4.2.SummaryDifference0.1%

- Check80 days agoChange DetectedA new revision entry (v3.4.2) was added, and notices about funding (v3.4.1) were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check88 days agoChange DetectedA site-wide notice about a lapse in government funding was added, directing users to cc.nih.gov and opm.gov, and the page revision was updated to v3.4.1 (replacing v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

Stay in the know with updates to HBI-8000 + Nivolumab vs. Nivolumab in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the HBI-8000 + Nivolumab vs. Nivolumab in Melanoma Clinical Trial page.